In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: Inhalation versus intraperitoneal injection

Pharmacology Biochemistry and Behavior

Volumn 124, Issue , 2014, Pages 40-47

  Marshell, R ^a   Kearney Ramos, T ^a   Brents, L K ^a   Hyatt, W S ^a   Tai, S ^a   Prather, P L ^a   Fantegrossi, W E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Antinociception; Behavior; Cannabinoids; Drug discrimination; Hypothermia; Locomotor activity

Indexed keywords

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; DRONABINOL; JWH 073; RIMONABANT; SODIUM CHLORIDE; UNCLASSIFIED DRUG; 1-PENTYL-3-(1-NAPHTHOYL)INDOLE; INDOLE DERIVATIVE; JWH-073; NAPHTHALENE DERIVATIVE;

ADULT; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISCRIMINATION TEST; DRUG EFFECT; DRUG EXPOSURE; EXPERIMENTAL CATALEPSY; EXPERIMENTAL HYPOTHERMIA; IN VIVO STUDY; INHALATION; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; METABOLITE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION ENERGY; REARING; RECTUM TEMPERATURE; TAIL FLICK TEST; ANIMAL; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ANIMALS; DRONABINOL; INDOLES; INJECTIONS, INTRAPERITONEAL; MALE; MICE; NAPHTHALENES;

EID: 84901833260     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.05.010     Document Type: Article

References (26)

1. B.K. Atwood, J. Huffman, A. Straiker, and K. Mackie JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist Br J Pharmacol 160 2010 585 593
2. L.K. Brents, E.E. Reichard, S.M. Zimmerman, J.H. Moran, W.E. Fantegrossi, and P.L. Prather Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity PLoS One 6 7 2011 e21917
3. L.K. Brents, A. Gallus-Zawada, A. Radominska-Pandya, T. Vasiljevik, T.E. Prisinzano, and W.E. Fantegrossi et al. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity Biochem Pharmacol 83 7 2012 952 961
4. L.K. Brents, S.M. Zimmerman, A.R. Saffell, P.L. Prather, and W.E. Fantegrossi Differential drug-drug interactions of the synthetic cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy J Pharmacol Exp Ther 346 3 2013 350 361
5. M.A. Eissenstat, M.R. Bell, T.E. D'Ambra, K.G. Estep, D.A. Haycock, and E.M. Olefirowicz et al. Aminoalkylindoles (AAIs): structurally novel cannabinoid-mimetics NIDA Res Monogr 105 1990 427 428
6. K.G. Estep, T.E. D'Ambra, E.M. Olefirowicz, M.R. Bell, M.A. Eissenstat, and D.A. Haycock et al. Conformationally restrained aminoalkylindoles: potent, stereoselective ligands at the cannabinoid binding site NIDA Res Monogr 105 1990 300 301
7. W.E. Fantegrossi, N. Murai, B.O. Mathúna, N. Pizarro, and R. de la Torre Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and its enantiomers in mice: pharmacokinetic considerations J Pharmacol Exp Ther 329 3 2009 1006 1015
8. L. Fattore, and W. Fratta Beyond THC: the new generation of cannabinoid designer drugs Front Behav Neurosci 5 2011 1 12
9. L. Fattore, G. Cossu, C.M. Martellotta, and W. Fratta Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats Psychopharmacology (Berlin) 156 2001 410 416 (Pubitemid 32695850)
10. Y. Gaoni, and R. Mechoulam Isolation, structure and partial synthesis of an active constituent of hashish J Am Chem Soc 86 1964 1646 1647
11. E.H. Jacobs, A.B. Smit, T.J. de Vries, and A.N. Schoffelmeer Neuroadaptive effects of active versus passive drug administration in addiction research Trends Pharmacol Sci 24 11 2003 566 573 (Pubitemid 37357140)
12. L.D. Johnston, P.M. O'Malley, J.G. Bachman, and J.E. Schulenberg Marijuana use continues to rise among U.S. teens, while alcohol use hits historic lows 2011 University of Michigan News Service Ann Arbor, MI [Accessed 16 Dec 2011 at http://www.monitoringthefuture.org ]
13. Z. Justinova, S.R. Goldberg, S.J. Heishman, and G. Tanda Self-administration of cannabinoids by experimental animals and human marijuana smokers Pharmacol Biochem Behav 81 2 2005 285 299 (Pubitemid 40807128)
14. R. Lindigkeit, A. Boehme, I. Eiserloh, M. Luebbecke, M. Wiggermann, and L. Ernst et al. Spice: a never ending story? Forensic Sci Int 191 2009 58 63
15. B.K. Logan, L.E. Reinhold, A. Xu, and F.X. Diamond Identification of synthetic cannabinoids in herbal incense blends in the United States J Forensic Sci 57 5 2012 1168 1180
16. M.C. Martellotta, G. Cossu, L. Fattore, G.L. Gessa, and W. Fratta Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice Neuroscience 85 1998 327 330 (Pubitemid 28218655)
17. B.R. Martin, D.R. Compton, B.F. Thomas, W.R. Prescott, P.J. Little, and R.K. Razdan et al. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs Pharmacol Biochem Behav 40 3 1991 471 478
18. K.S. Murnane, N. Murai, L.L. Howell, and W.E. Fantegrossi Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4- methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice J Pharmacol Exp Ther 331 2 2009 717 723
19. M. Navarro, M.R. Carrera, W. Fratta, O. Valverde, G. Cossu, and L. Fattore et al. Functional interaction between opioid and cannabinoid receptors in drug self-administration J Neurosci 21 2001 5344 5350 (Pubitemid 32622960)
20. S.M. Pond, and T.N. Tozer First-pass elimination. Basic concepts and clinical consequences Clin Pharmacokinet 9 1 1984 1 25 (Pubitemid 14180304)
21. K.A. Seely, J. Lapoint, J.H. Moran, and L. Fattore Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids Prog Neuropsychopharmacol Biol Psychiatry 39 2 2012 234 243
22. K.A. Seely, A.L. Patton, C.L. Moran, M.L. Womack, P.L. Prather, and W.E. Fantegrossi et al. Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds Forensic Sci Int 233 1-3 2013 416 422
23. V. Sharma, and J.H. McNeill To scale or not to scale: the principles of dose extrapolation Br J Pharmacol 157 6 2009 907 921
24. R. Vandrey, K.E. Dunn, J.A. Fry, and E.R. Girling A survey study to characterize use of Spice products (synthetic cannabinoids) Drug Alcohol Depend 120 1-3 2012 238 241
25. I. Vardakou, C. Pistos, and Ch. Spiliopoulou Spice drugs as a new trend: mode of action, identification and legislation Toxicol Lett 197 3 2010 157 162
26. J.M. Wiebelhaus, J.L. Poklis, A. Poklis, R.E. Vann, A.H. Lichtman, and L.E. Wise Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice Drug Alcohol Depend 126 3 2012 316 322